These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26015812)

  • 1. Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.
    Prattichizzo F; Giuliani A; Ceka A; Rippo MR; Bonfigli AR; Testa R; Procopio AD; Olivieri F
    Clin Epigenetics; 2015; 7(1):56. PubMed ID: 26015812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epigenetic mechanisms in the development of chronic complications of diabetes.
    Wegner M; Neddermann D; Piorunska-Stolzmann M; Jagodzinski PP
    Diabetes Res Clin Pract; 2014 Aug; 105(2):164-75. PubMed ID: 24814876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
    Prattichizzo F; Giuliani A; De Nigris V; Pujadas G; Ceka A; La Sala L; Genovese S; Testa R; Procopio AD; Olivieri F; Ceriello A
    Diabetes Obes Metab; 2016 Sep; 18(9):855-67. PubMed ID: 27161301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic effects of physical activity in elderly patients with cardiovascular disease.
    Recchioni R; Marcheselli F; Antonicelli R; Mensà E; Lazzarini R; Procopio AD; Olivieri F
    Exp Gerontol; 2017 Dec; 100():17-27. PubMed ID: 29074290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.
    Paneni F; Costantino S; Battista R; Castello L; Capretti G; Chiandotto S; Scavone G; Villano A; Pitocco D; Lanza G; Volpe M; Lüscher TF; Cosentino F
    Circ Cardiovasc Genet; 2015 Feb; 8(1):150-8. PubMed ID: 25472959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
    Coco C; Sgarra L; Potenza MA; Nacci C; Pasculli B; Barbano R; Parrella P; Montagnani M
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
    Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
    Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of diet and exercise in the transgenerational epigenetic landscape of T2DM.
    Barrès R; Zierath JR
    Nat Rev Endocrinol; 2016 Aug; 12(8):441-51. PubMed ID: 27312865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in genetic and epigenetic research on type 2 diabetes.
    Kwak SH; Park KS
    Exp Mol Med; 2016 Mar; 48(3):e220. PubMed ID: 26964836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.
    Arif KMT; Elliott EK; Haupt LM; Griffiths LR
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular epigenetics: from DNA methylation to microRNAs.
    Udali S; Guarini P; Moruzzi S; Choi SW; Friso S
    Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players.
    Alexandru N; Badila E; Weiss E; Cochior D; Stępień E; Georgescu A
    Biochem Biophys Res Commun; 2016 Mar; 472(1):1-10. PubMed ID: 26891868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.
    Pradhan P; Upadhyay N; Tiwari A; Singh LP
    New Front Ophthalmol; 2016; 2(5):192-204. PubMed ID: 28691104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of Wound Healing in Patients With Type 2 Diabetes Mellitus Influences Circulating MicroRNA Patterns via Inflammatory Cytokines.
    Dangwal S; Stratmann B; Bang C; Lorenzen JM; Kumarswamy R; Fiedler J; Falk CS; Scholz CJ; Thum T; Tschoepe D
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1480-8. PubMed ID: 25814674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.
    Olivieri F; Spazzafumo L; Bonafè M; Recchioni R; Prattichizzo F; Marcheselli F; Micolucci L; Mensà E; Giuliani A; Santini G; Gobbi M; Lazzarini R; Boemi M; Testa R; Antonicelli R; Procopio AD; Bonfigli AR
    Oncotarget; 2015 Nov; 6(34):35372-82. PubMed ID: 26498351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.